Adaptive biotechnologies stock.

Adaptive Biotechnologies Corp Follow Share $4.62 After Hours: $4.62 (0.00%) 0.00 Closed: Nov 29, 4:18:17 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to AbbVie Inc $138.50 ABBV0.0072%... Get the latest Adaptive Biotechnologies Corporation (ADPT) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, research reports and more for ADPT on NasdaqGS. Get the latest Adaptive Biotechnologies Corporation (ADPT) stock news and headlines to help you in your trading and investing decisions. ... Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 ...Employment: Adaptive Biotechnologies. Stock and Other Ownership Interests: Adaptive Biotechnologies. Lik Wee Lee. Employment: Adaptive Biotechnologies. Crystal L. Mackall. Stock and Other Ownership Interests: Lyell Immunopharma, Alimera Sciences, Vor Pharmaceuticals, Apricity Health, Syncopation …Nov 17, 2023 · Adaptive Biotechnologies is forecast to grow earnings and revenue by 18.8% and 23.1% per annum respectively. EPS is expected to grow by 21.8% per annum. Return on equity is forecast to be -56.8% in 3 years.

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript November 9, 2023 Adaptive Biotechnologies Corporation misses on earnings …Stock analysis for Adaptive Biotechnologies Corp (ADPT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest Adaptive Biotechnologies Corp (ADPT) real-time quote, historical performance, charts, and other financial information to help you...

Adaptive Biotechnologies. Wood has bought almost 10 million shares of this stock for her ARK Genomic Revolution fund. Adaptive Biotechnologies Corp. ( NASDAQ: ADPT ) is a commercial-stage company ...Nov 9, 2023 · SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ... Adaptive Biotechnologies is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Adaptive Biotechnologies's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Adaptive Biotechnologies or its management.Meet Adaptive. The adaptive immune system is a force inside your body so powerful it’s able to detect disease and fight it, often before you even realize that you’re sick. Adaptive Biotechnologies is harnessing this vast system of biology to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine.

Nov 17, 2023 · Adaptive Biotechnologies is forecast to grow earnings and revenue by 18.8% and 23.1% per annum respectively. EPS is expected to grow by 21.8% per annum. Return on equity is forecast to be -56.8% in 3 years.

Track Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

You can buy or sell ADPT and other ETFs, options, and stocks. Sign up. About ADPT. Adaptive Biotechnologies Corp. engages in the development of an immune ...The upgrade of Adaptive Biotechnologies to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...May 26, 2023 · The growth-stock investor added to her stakes in UiPath (PATH 26.72%), Prime Medicine (PRME 11.02%), and Adaptive Biotechnologies (ADPT 7.31%) on Thursday. What does Wood see in these three ... In summary, Adaptive Biotechnologies Corp (ADPT) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.Adaptive Biotechnologies (ADPT) Stock Forecast & Price Target

You can buy or sell ADPT and other ETFs, options, and stocks. Sign up. About ADPT. Adaptive Biotechnologies Corp. engages in the development of an immune ...Get the latest Adaptive Biotechnologies Corp (ADPT) real-time quote, historical performance, charts, and other financial information to help you make more informed …Jun 16, 2023 · Shares of Adaptive Biotechnologies ... The clinical-stage biotech company's stock closed last week at $7.31, then rose to as high as $9.08 on Wednesday. The stock is up a little more than 10% so ... 6. Adaptive Biotechnologies -- $6 a share. Adaptive Biotechnologies ( ADPT 6.95%) may get cheaper in the short-term, but this biotech has an exciting platform that should unlock a lot of value ...THOUSAND OAKS, Calif., and SEATTLE, April 2, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing …Adaptive Biotechnologies Corporation (ADPT.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Adaptive Biotechnologies ...Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen closed nearly 83% …

As of June 02, 2023, 4:00 PM CST, Adaptive Biotechnologies Corp’s stock price was $7.46. Adaptive Biotechnologies Corp is up 5.82% from its previous closing price of $7.05. During the last market session, Adaptive Biotechnologies Corp’s stock traded between $6.76 and $7.14. Currently, there are 143.51 million shares of Adaptive ...

ADPT Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) 6.64. at close.Samples were sent overnight at ambient temperature to Adaptive Biotechnologies (Seattle, WA) for processing. Plasma was isolated within 5 days of collection. ctDNA levels were subsequently determined from isolated plasma via next-generation sequence as described. 13 Clinicians did not have these data available at the …The stock is down 50% post the news. ... Some other top-ranked stocks in the overall healthcare sector include Adaptive Biotechnologies Corporation ADPT, ...SEATTLE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced the launch of its clonoSEQ ® Assay to detect minimal residual disease ...SEATTLE, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended ...SEATTLE, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth …

Adaptive Biotechnologies Corp is down 12.44% from its previous closing price of $7.96. During the last market session, Adaptive Biotechnologies Corp’s stock traded between $7.87 and $8.10. Currently, there are 143.51 million shares of Adaptive Biotechnologies Corp stock available for purchase. Unfortunately, Adaptive …

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.44 per share a year ago.

The institutional investor acquired 53,400 shares of the company’s stock, corresponding to a value of approximately $472,000. Adaptive Biotechnologies Co., listed on NASDAQ under the symbol ADPT, opened at $6.17 on Tuesday. Over the past year, its stock has ranged between a low of $5.96 and a high of $10.79.Dec 1, 2022 · SEATTLE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced the launch of its clonoSEQ ® Assay to detect minimal residual disease ... Adaptive Biotechnologies has an immune medicine platform used for sequencing T cells and developing a wide array of diagnostic and clinical products. ... If a stock tanks 80%, ...Adaptive Biotechnologies, like the other stocks on this list, carries a market valuation that has a lot of future success baked in. Wood's been buying these stocks lately, but none carry a weight ...Dec 1, 2023 · Adaptive Biotechnologies - ADPT - Stock Price Today - Zacks Adaptive Biotechnologies (ADPT) (Delayed Data from NSDQ) $4.37 USD +0.12 (2.82%) Updated Nov 24, 2023 12:59 PM ET After-Market:... The upgrade of Adaptive Biotechnologies to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...Discover historical prices for ADPT stock on Yahoo Finance. View daily, weekly or monthly format back to when Adaptive Biotechnologies Corporation stock was issued.Adaptive Biotechnologies is a company in transition that has lost 90% of its value in the past couple years. Read why I see no investible angle in ADPT stock.The stock is down 50% post the news. ... Some other top-ranked stocks in the overall healthcare sector include Adaptive Biotechnologies Corporation ADPT, ...

2009. 790. Chad Robins. https://www.adaptivebiotech.com. Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions ...Jun 2, 2023 · As of June 02, 2023, 4:00 PM CST, Adaptive Biotechnologies Corp’s stock price was $7.46. Adaptive Biotechnologies Corp is up 5.82% from its previous closing price of $7.05. During the last market session, Adaptive Biotechnologies Corp’s stock traded between $6.76 and $7.14. Currently, there are 143.51 million shares of Adaptive ... Nov 30, 2023 · The average twelve-month price prediction for Adaptive Biotechnologies is $9.50 with a high price target of $15.00 and a low price target of $6.00. Learn more on ADPT's analyst rating history. Do Wall Street analysts like Adaptive Biotechnologies more than its competitors? Analysts like Adaptive Biotechnologies less than other Medical companies. Adaptive Biotechnologies Corp’s Stock Price as of Market Close. As of April 11, 2023, 4:00 PM CST, Adaptive Biotechnologies Corp’s stock price was $8.17. Adaptive Biotechnologies Corp is down 4.89% from its previous closing price of $8.59. During the last market session, Adaptive Biotechnologies Corp’s stock traded between $8.33 and $8.61.Instagram:https://instagram. forex trade signalday trader guidejohn deere stock dividendshort term health insurance nevada Nov 29, 2023 · What percentage of Adaptive Biotechnologies stock is owned by insiders? 5.20% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings. why is fcel stock so lownyse clx According to the Biotechnology Industry Organization, there are more than 250 biotechnology products available, including medicines, vaccines, fertilizers, pest-resistant crops, bio-fuels and bio-defense products. best desktop wallet crypto Track Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAdaptive Biotechnologies Corporation Common Stock (ADPT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.